Expertise in
6
conditions

Siddharthan P. Chandran

Edinburgh, SCT, GB 
Expertise in
6
conditions
Edinburgh, SCT, GB 

Overview

Siddharthan Chandran practices practicing medicine in Edinburgh, United Kingdom.

Chandran is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Gastrostomy.

They are actively involved in clinical research, co-authoring 232 peer reviewed articles and participating in 2 clinical trials.

Locations

Edinburgh, SCT, United Kingdom
Other Locations
London, ENG, United Kingdom
SCT, United Kingdom
North Western Deanery
Manchester, ENG, United Kingdom
North Western Deanery
Oldham, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomised, Double Blind, Clinical Trial Investigating the Effectiveness of Repurposed Simvastatin Compared to Placebo, in Secondary Progressive Multiple Sclerosis, in Slowing the Progression of Disability
A Phase 3 Randomised, Double Blind, Clinical Trial Investigating the Effectiveness of Repurposed Simvastatin Compared to Placebo, in Secondary Progressive Multiple Sclerosis, in Slowing the Progression of Disability
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Simvastatin
Study Phase: Phase 3
Genomic Translation for Amyotrophic Lateral Sclerosis Care
Genomic Translation for Amyotrophic Lateral Sclerosis Care
Enrollment Status: Completed
Publish Date: August 19, 2022
View 1 Less Clinical Trial

232 Total Publications

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
Journal: Health technology assessment (Winchester, England)
Published: June 29, 2026

Frequently Asked Questions about Siddharthan P. Chandran

Is Siddharthan P. Chandran a top-rated expert for Primary Lateral Sclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Siddharthan P. Chandran is classified as an Elite expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Siddharthan P. Chandran participate in research or clinical trials?

Yes. Siddharthan P. Chandran has published 232 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Siddharthan P. Chandran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chandran's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile